nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenidate—Cardiac disorder—Epirubicin—stomach cancer	0.000439	0.000439	CcSEcCtD
Methylphenidate—Flushing—Epirubicin—stomach cancer	0.000439	0.000439	CcSEcCtD
Methylphenidate—Vomiting—Fluorouracil—stomach cancer	0.000439	0.000439	CcSEcCtD
Methylphenidate—Rhinitis—Doxorubicin—stomach cancer	0.000439	0.000439	CcSEcCtD
Methylphenidate—Dyspepsia—Docetaxel—stomach cancer	0.000439	0.000439	CcSEcCtD
Methylphenidate—Haemorrhage—Doxorubicin—stomach cancer	0.000438	0.000438	CcSEcCtD
Methylphenidate—Insomnia—Capecitabine—stomach cancer	0.000436	0.000436	CcSEcCtD
Methylphenidate—Rash—Fluorouracil—stomach cancer	0.000435	0.000435	CcSEcCtD
Methylphenidate—Dermatitis—Fluorouracil—stomach cancer	0.000435	0.000435	CcSEcCtD
Methylphenidate—Pharyngitis—Doxorubicin—stomach cancer	0.000435	0.000435	CcSEcCtD
Methylphenidate—Paraesthesia—Capecitabine—stomach cancer	0.000433	0.000433	CcSEcCtD
Methylphenidate—Decreased appetite—Docetaxel—stomach cancer	0.000433	0.000433	CcSEcCtD
Methylphenidate—Headache—Fluorouracil—stomach cancer	0.000433	0.000433	CcSEcCtD
Methylphenidate—Urinary tract disorder—Doxorubicin—stomach cancer	0.000432	0.000432	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Docetaxel—stomach cancer	0.00043	0.00043	CcSEcCtD
Methylphenidate—Connective tissue disorder—Doxorubicin—stomach cancer	0.00043	0.00043	CcSEcCtD
Methylphenidate—Dyspnoea—Capecitabine—stomach cancer	0.00043	0.00043	CcSEcCtD
Methylphenidate—Fatigue—Docetaxel—stomach cancer	0.00043	0.00043	CcSEcCtD
Methylphenidate—Angiopathy—Epirubicin—stomach cancer	0.000429	0.000429	CcSEcCtD
Methylphenidate—Urethral disorder—Doxorubicin—stomach cancer	0.000429	0.000429	CcSEcCtD
Methylphenidate—Nausea—Irinotecan—stomach cancer	0.000428	0.000428	CcSEcCtD
Methylphenidate—Immune system disorder—Epirubicin—stomach cancer	0.000427	0.000427	CcSEcCtD
Methylphenidate—Mediastinal disorder—Epirubicin—stomach cancer	0.000426	0.000426	CcSEcCtD
Methylphenidate—Pain—Docetaxel—stomach cancer	0.000426	0.000426	CcSEcCtD
Methylphenidate—Constipation—Docetaxel—stomach cancer	0.000426	0.000426	CcSEcCtD
Methylphenidate—Back pain—Methotrexate—stomach cancer	0.000426	0.000426	CcSEcCtD
Methylphenidate—Dyspepsia—Capecitabine—stomach cancer	0.000425	0.000425	CcSEcCtD
Methylphenidate—Chills—Epirubicin—stomach cancer	0.000425	0.000425	CcSEcCtD
Methylphenidate—Arrhythmia—Epirubicin—stomach cancer	0.000423	0.000423	CcSEcCtD
Methylphenidate—Visual impairment—Doxorubicin—stomach cancer	0.000422	0.000422	CcSEcCtD
Methylphenidate—Decreased appetite—Capecitabine—stomach cancer	0.000419	0.000419	CcSEcCtD
Methylphenidate—Alopecia—Epirubicin—stomach cancer	0.000418	0.000418	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000417	0.000417	CcSEcCtD
Methylphenidate—Fatigue—Capecitabine—stomach cancer	0.000416	0.000416	CcSEcCtD
Methylphenidate—Vision blurred—Methotrexate—stomach cancer	0.000415	0.000415	CcSEcCtD
Methylphenidate—Mental disorder—Epirubicin—stomach cancer	0.000415	0.000415	CcSEcCtD
Methylphenidate—Erythema multiforme—Doxorubicin—stomach cancer	0.000414	0.000414	CcSEcCtD
Methylphenidate—Constipation—Capecitabine—stomach cancer	0.000413	0.000413	CcSEcCtD
Methylphenidate—Pain—Capecitabine—stomach cancer	0.000413	0.000413	CcSEcCtD
Methylphenidate—Erythema—Epirubicin—stomach cancer	0.000412	0.000412	CcSEcCtD
Methylphenidate—Malnutrition—Epirubicin—stomach cancer	0.000412	0.000412	CcSEcCtD
Methylphenidate—Feeling abnormal—Docetaxel—stomach cancer	0.000411	0.000411	CcSEcCtD
Methylphenidate—Nausea—Fluorouracil—stomach cancer	0.00041	0.00041	CcSEcCtD
Methylphenidate—Eye disorder—Doxorubicin—stomach cancer	0.000409	0.000409	CcSEcCtD
Methylphenidate—Ill-defined disorder—Methotrexate—stomach cancer	0.000408	0.000408	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Docetaxel—stomach cancer	0.000408	0.000408	CcSEcCtD
Methylphenidate—Anaemia—Methotrexate—stomach cancer	0.000407	0.000407	CcSEcCtD
Methylphenidate—Cardiac disorder—Doxorubicin—stomach cancer	0.000406	0.000406	CcSEcCtD
Methylphenidate—Flushing—Doxorubicin—stomach cancer	0.000406	0.000406	CcSEcCtD
Methylphenidate—Tension—Epirubicin—stomach cancer	0.000404	0.000404	CcSEcCtD
Methylphenidate—Nervousness—Epirubicin—stomach cancer	0.0004	0.0004	CcSEcCtD
Methylphenidate—Back pain—Epirubicin—stomach cancer	0.000398	0.000398	CcSEcCtD
Methylphenidate—Feeling abnormal—Capecitabine—stomach cancer	0.000398	0.000398	CcSEcCtD
Methylphenidate—Angiopathy—Doxorubicin—stomach cancer	0.000397	0.000397	CcSEcCtD
Methylphenidate—Malaise—Methotrexate—stomach cancer	0.000397	0.000397	CcSEcCtD
Methylphenidate—Muscle spasms—Epirubicin—stomach cancer	0.000396	0.000396	CcSEcCtD
Methylphenidate—Immune system disorder—Doxorubicin—stomach cancer	0.000395	0.000395	CcSEcCtD
Methylphenidate—Vertigo—Methotrexate—stomach cancer	0.000395	0.000395	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Capecitabine—stomach cancer	0.000395	0.000395	CcSEcCtD
Methylphenidate—Mediastinal disorder—Doxorubicin—stomach cancer	0.000395	0.000395	CcSEcCtD
Methylphenidate—Abdominal pain—Docetaxel—stomach cancer	0.000394	0.000394	CcSEcCtD
Methylphenidate—Body temperature increased—Docetaxel—stomach cancer	0.000394	0.000394	CcSEcCtD
Methylphenidate—Leukopenia—Methotrexate—stomach cancer	0.000394	0.000394	CcSEcCtD
Methylphenidate—Chills—Doxorubicin—stomach cancer	0.000393	0.000393	CcSEcCtD
Methylphenidate—Arrhythmia—Doxorubicin—stomach cancer	0.000391	0.000391	CcSEcCtD
Methylphenidate—Vision blurred—Epirubicin—stomach cancer	0.000388	0.000388	CcSEcCtD
Methylphenidate—Alopecia—Doxorubicin—stomach cancer	0.000387	0.000387	CcSEcCtD
Methylphenidate—Cough—Methotrexate—stomach cancer	0.000384	0.000384	CcSEcCtD
Methylphenidate—Mental disorder—Doxorubicin—stomach cancer	0.000384	0.000384	CcSEcCtD
Methylphenidate—Urticaria—Capecitabine—stomach cancer	0.000383	0.000383	CcSEcCtD
Methylphenidate—Ill-defined disorder—Epirubicin—stomach cancer	0.000382	0.000382	CcSEcCtD
Methylphenidate—Abdominal pain—Capecitabine—stomach cancer	0.000381	0.000381	CcSEcCtD
Methylphenidate—Body temperature increased—Capecitabine—stomach cancer	0.000381	0.000381	CcSEcCtD
Methylphenidate—Convulsion—Methotrexate—stomach cancer	0.000381	0.000381	CcSEcCtD
Methylphenidate—Malnutrition—Doxorubicin—stomach cancer	0.000381	0.000381	CcSEcCtD
Methylphenidate—Erythema—Doxorubicin—stomach cancer	0.000381	0.000381	CcSEcCtD
Methylphenidate—Anaemia—Epirubicin—stomach cancer	0.000381	0.000381	CcSEcCtD
Methylphenidate—Agitation—Epirubicin—stomach cancer	0.000379	0.000379	CcSEcCtD
Methylphenidate—Arthralgia—Methotrexate—stomach cancer	0.000375	0.000375	CcSEcCtD
Methylphenidate—Chest pain—Methotrexate—stomach cancer	0.000375	0.000375	CcSEcCtD
Methylphenidate—Myalgia—Methotrexate—stomach cancer	0.000375	0.000375	CcSEcCtD
Methylphenidate—Tension—Doxorubicin—stomach cancer	0.000374	0.000374	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000372	0.000372	CcSEcCtD
Methylphenidate—Malaise—Epirubicin—stomach cancer	0.000371	0.000371	CcSEcCtD
Methylphenidate—Discomfort—Methotrexate—stomach cancer	0.00037	0.00037	CcSEcCtD
Methylphenidate—Nervousness—Doxorubicin—stomach cancer	0.00037	0.00037	CcSEcCtD
Methylphenidate—Vertigo—Epirubicin—stomach cancer	0.00037	0.00037	CcSEcCtD
Methylphenidate—Syncope—Epirubicin—stomach cancer	0.000369	0.000369	CcSEcCtD
Methylphenidate—Leukopenia—Epirubicin—stomach cancer	0.000369	0.000369	CcSEcCtD
Methylphenidate—Back pain—Doxorubicin—stomach cancer	0.000369	0.000369	CcSEcCtD
Methylphenidate—Hypersensitivity—Docetaxel—stomach cancer	0.000367	0.000367	CcSEcCtD
Methylphenidate—Muscle spasms—Doxorubicin—stomach cancer	0.000366	0.000366	CcSEcCtD
Methylphenidate—Palpitations—Epirubicin—stomach cancer	0.000364	0.000364	CcSEcCtD
Methylphenidate—Confusional state—Methotrexate—stomach cancer	0.000362	0.000362	CcSEcCtD
Methylphenidate—Loss of consciousness—Epirubicin—stomach cancer	0.000362	0.000362	CcSEcCtD
Methylphenidate—Cough—Epirubicin—stomach cancer	0.000359	0.000359	CcSEcCtD
Methylphenidate—Anaphylactic shock—Methotrexate—stomach cancer	0.000359	0.000359	CcSEcCtD
Methylphenidate—Vision blurred—Doxorubicin—stomach cancer	0.000359	0.000359	CcSEcCtD
Methylphenidate—Asthenia—Docetaxel—stomach cancer	0.000358	0.000358	CcSEcCtD
Methylphenidate—Convulsion—Epirubicin—stomach cancer	0.000357	0.000357	CcSEcCtD
Methylphenidate—Infection—Methotrexate—stomach cancer	0.000357	0.000357	CcSEcCtD
Methylphenidate—Hypertension—Epirubicin—stomach cancer	0.000356	0.000356	CcSEcCtD
Methylphenidate—Hypersensitivity—Capecitabine—stomach cancer	0.000356	0.000356	CcSEcCtD
Methylphenidate—Ill-defined disorder—Doxorubicin—stomach cancer	0.000354	0.000354	CcSEcCtD
Methylphenidate—Pruritus—Docetaxel—stomach cancer	0.000353	0.000353	CcSEcCtD
Methylphenidate—Nervous system disorder—Methotrexate—stomach cancer	0.000352	0.000352	CcSEcCtD
Methylphenidate—Anaemia—Doxorubicin—stomach cancer	0.000352	0.000352	CcSEcCtD
Methylphenidate—Thrombocytopenia—Methotrexate—stomach cancer	0.000352	0.000352	CcSEcCtD
Methylphenidate—Chest pain—Epirubicin—stomach cancer	0.000351	0.000351	CcSEcCtD
Methylphenidate—Arthralgia—Epirubicin—stomach cancer	0.000351	0.000351	CcSEcCtD
Methylphenidate—Myalgia—Epirubicin—stomach cancer	0.000351	0.000351	CcSEcCtD
Methylphenidate—Agitation—Doxorubicin—stomach cancer	0.00035	0.00035	CcSEcCtD
Methylphenidate—Anxiety—Epirubicin—stomach cancer	0.000349	0.000349	CcSEcCtD
Methylphenidate—Skin disorder—Methotrexate—stomach cancer	0.000349	0.000349	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000348	0.000348	CcSEcCtD
Methylphenidate—Hyperhidrosis—Methotrexate—stomach cancer	0.000347	0.000347	CcSEcCtD
Methylphenidate—Discomfort—Epirubicin—stomach cancer	0.000346	0.000346	CcSEcCtD
Methylphenidate—Asthenia—Capecitabine—stomach cancer	0.000346	0.000346	CcSEcCtD
Methylphenidate—Malaise—Doxorubicin—stomach cancer	0.000344	0.000344	CcSEcCtD
Methylphenidate—Dry mouth—Epirubicin—stomach cancer	0.000343	0.000343	CcSEcCtD
Methylphenidate—Vertigo—Doxorubicin—stomach cancer	0.000342	0.000342	CcSEcCtD
Methylphenidate—Anorexia—Methotrexate—stomach cancer	0.000342	0.000342	CcSEcCtD
Methylphenidate—Syncope—Doxorubicin—stomach cancer	0.000342	0.000342	CcSEcCtD
Methylphenidate—Pruritus—Capecitabine—stomach cancer	0.000341	0.000341	CcSEcCtD
Methylphenidate—Leukopenia—Doxorubicin—stomach cancer	0.000341	0.000341	CcSEcCtD
Methylphenidate—Diarrhoea—Docetaxel—stomach cancer	0.000341	0.000341	CcSEcCtD
Methylphenidate—Confusional state—Epirubicin—stomach cancer	0.000339	0.000339	CcSEcCtD
Methylphenidate—Palpitations—Doxorubicin—stomach cancer	0.000337	0.000337	CcSEcCtD
Methylphenidate—Anaphylactic shock—Epirubicin—stomach cancer	0.000336	0.000336	CcSEcCtD
Methylphenidate—Oedema—Epirubicin—stomach cancer	0.000336	0.000336	CcSEcCtD
Methylphenidate—Loss of consciousness—Doxorubicin—stomach cancer	0.000335	0.000335	CcSEcCtD
Methylphenidate—Infection—Epirubicin—stomach cancer	0.000334	0.000334	CcSEcCtD
Methylphenidate—Cough—Doxorubicin—stomach cancer	0.000333	0.000333	CcSEcCtD
Methylphenidate—Shock—Epirubicin—stomach cancer	0.000331	0.000331	CcSEcCtD
Methylphenidate—Convulsion—Doxorubicin—stomach cancer	0.00033	0.00033	CcSEcCtD
Methylphenidate—Diarrhoea—Capecitabine—stomach cancer	0.00033	0.00033	CcSEcCtD
Methylphenidate—Nervous system disorder—Epirubicin—stomach cancer	0.00033	0.00033	CcSEcCtD
Methylphenidate—Dizziness—Docetaxel—stomach cancer	0.00033	0.00033	CcSEcCtD
Methylphenidate—Thrombocytopenia—Epirubicin—stomach cancer	0.000329	0.000329	CcSEcCtD
Methylphenidate—Hypertension—Doxorubicin—stomach cancer	0.000329	0.000329	CcSEcCtD
Methylphenidate—Tachycardia—Epirubicin—stomach cancer	0.000328	0.000328	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000327	0.000327	CcSEcCtD
Methylphenidate—Skin disorder—Epirubicin—stomach cancer	0.000327	0.000327	CcSEcCtD
Methylphenidate—Hyperhidrosis—Epirubicin—stomach cancer	0.000325	0.000325	CcSEcCtD
Methylphenidate—Insomnia—Methotrexate—stomach cancer	0.000325	0.000325	CcSEcCtD
Methylphenidate—Chest pain—Doxorubicin—stomach cancer	0.000324	0.000324	CcSEcCtD
Methylphenidate—Myalgia—Doxorubicin—stomach cancer	0.000324	0.000324	CcSEcCtD
Methylphenidate—Arthralgia—Doxorubicin—stomach cancer	0.000324	0.000324	CcSEcCtD
Methylphenidate—Anxiety—Doxorubicin—stomach cancer	0.000323	0.000323	CcSEcCtD
Methylphenidate—Paraesthesia—Methotrexate—stomach cancer	0.000323	0.000323	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000322	0.000322	CcSEcCtD
Methylphenidate—Discomfort—Doxorubicin—stomach cancer	0.000321	0.000321	CcSEcCtD
Methylphenidate—Anorexia—Epirubicin—stomach cancer	0.00032	0.00032	CcSEcCtD
Methylphenidate—Dyspnoea—Methotrexate—stomach cancer	0.00032	0.00032	CcSEcCtD
Methylphenidate—Somnolence—Methotrexate—stomach cancer	0.000319	0.000319	CcSEcCtD
Methylphenidate—Dizziness—Capecitabine—stomach cancer	0.000319	0.000319	CcSEcCtD
Methylphenidate—Dry mouth—Doxorubicin—stomach cancer	0.000317	0.000317	CcSEcCtD
Methylphenidate—Vomiting—Docetaxel—stomach cancer	0.000317	0.000317	CcSEcCtD
Methylphenidate—Dyspepsia—Methotrexate—stomach cancer	0.000316	0.000316	CcSEcCtD
Methylphenidate—Rash—Docetaxel—stomach cancer	0.000314	0.000314	CcSEcCtD
Methylphenidate—Dermatitis—Docetaxel—stomach cancer	0.000314	0.000314	CcSEcCtD
Methylphenidate—Confusional state—Doxorubicin—stomach cancer	0.000314	0.000314	CcSEcCtD
Methylphenidate—Decreased appetite—Methotrexate—stomach cancer	0.000312	0.000312	CcSEcCtD
Methylphenidate—Headache—Docetaxel—stomach cancer	0.000312	0.000312	CcSEcCtD
Methylphenidate—Anaphylactic shock—Doxorubicin—stomach cancer	0.000311	0.000311	CcSEcCtD
Methylphenidate—Oedema—Doxorubicin—stomach cancer	0.000311	0.000311	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Methotrexate—stomach cancer	0.00031	0.00031	CcSEcCtD
Methylphenidate—Fatigue—Methotrexate—stomach cancer	0.00031	0.00031	CcSEcCtD
Methylphenidate—Infection—Doxorubicin—stomach cancer	0.000309	0.000309	CcSEcCtD
Methylphenidate—Pain—Methotrexate—stomach cancer	0.000307	0.000307	CcSEcCtD
Methylphenidate—Vomiting—Capecitabine—stomach cancer	0.000307	0.000307	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000306	0.000306	CcSEcCtD
Methylphenidate—Shock—Doxorubicin—stomach cancer	0.000306	0.000306	CcSEcCtD
Methylphenidate—Nervous system disorder—Doxorubicin—stomach cancer	0.000305	0.000305	CcSEcCtD
Methylphenidate—Thrombocytopenia—Doxorubicin—stomach cancer	0.000305	0.000305	CcSEcCtD
Methylphenidate—Rash—Capecitabine—stomach cancer	0.000304	0.000304	CcSEcCtD
Methylphenidate—Insomnia—Epirubicin—stomach cancer	0.000304	0.000304	CcSEcCtD
Methylphenidate—Dermatitis—Capecitabine—stomach cancer	0.000304	0.000304	CcSEcCtD
Methylphenidate—Tachycardia—Doxorubicin—stomach cancer	0.000304	0.000304	CcSEcCtD
Methylphenidate—Headache—Capecitabine—stomach cancer	0.000302	0.000302	CcSEcCtD
Methylphenidate—Skin disorder—Doxorubicin—stomach cancer	0.000302	0.000302	CcSEcCtD
Methylphenidate—Paraesthesia—Epirubicin—stomach cancer	0.000302	0.000302	CcSEcCtD
Methylphenidate—Hyperhidrosis—Doxorubicin—stomach cancer	0.000301	0.000301	CcSEcCtD
Methylphenidate—Dyspnoea—Epirubicin—stomach cancer	0.0003	0.0003	CcSEcCtD
Methylphenidate—Somnolence—Epirubicin—stomach cancer	0.000299	0.000299	CcSEcCtD
Methylphenidate—Anorexia—Doxorubicin—stomach cancer	0.000296	0.000296	CcSEcCtD
Methylphenidate—Nausea—Docetaxel—stomach cancer	0.000296	0.000296	CcSEcCtD
Methylphenidate—Feeling abnormal—Methotrexate—stomach cancer	0.000296	0.000296	CcSEcCtD
Methylphenidate—Dyspepsia—Epirubicin—stomach cancer	0.000296	0.000296	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Methotrexate—stomach cancer	0.000294	0.000294	CcSEcCtD
Methylphenidate—Decreased appetite—Epirubicin—stomach cancer	0.000292	0.000292	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Epirubicin—stomach cancer	0.00029	0.00029	CcSEcCtD
Methylphenidate—Fatigue—Epirubicin—stomach cancer	0.00029	0.00029	CcSEcCtD
Methylphenidate—Pain—Epirubicin—stomach cancer	0.000287	0.000287	CcSEcCtD
Methylphenidate—Constipation—Epirubicin—stomach cancer	0.000287	0.000287	CcSEcCtD
Methylphenidate—Nausea—Capecitabine—stomach cancer	0.000287	0.000287	CcSEcCtD
Methylphenidate—Urticaria—Methotrexate—stomach cancer	0.000285	0.000285	CcSEcCtD
Methylphenidate—Body temperature increased—Methotrexate—stomach cancer	0.000284	0.000284	CcSEcCtD
Methylphenidate—Abdominal pain—Methotrexate—stomach cancer	0.000284	0.000284	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000283	0.000283	CcSEcCtD
Methylphenidate—Insomnia—Doxorubicin—stomach cancer	0.000281	0.000281	CcSEcCtD
Methylphenidate—Paraesthesia—Doxorubicin—stomach cancer	0.000279	0.000279	CcSEcCtD
Methylphenidate—Dyspnoea—Doxorubicin—stomach cancer	0.000277	0.000277	CcSEcCtD
Methylphenidate—Feeling abnormal—Epirubicin—stomach cancer	0.000277	0.000277	CcSEcCtD
Methylphenidate—Somnolence—Doxorubicin—stomach cancer	0.000277	0.000277	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Epirubicin—stomach cancer	0.000275	0.000275	CcSEcCtD
Methylphenidate—Dyspepsia—Doxorubicin—stomach cancer	0.000274	0.000274	CcSEcCtD
Methylphenidate—Decreased appetite—Doxorubicin—stomach cancer	0.00027	0.00027	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000269	0.000269	CcSEcCtD
Methylphenidate—Fatigue—Doxorubicin—stomach cancer	0.000268	0.000268	CcSEcCtD
Methylphenidate—Urticaria—Epirubicin—stomach cancer	0.000267	0.000267	CcSEcCtD
Methylphenidate—Pain—Doxorubicin—stomach cancer	0.000266	0.000266	CcSEcCtD
Methylphenidate—Constipation—Doxorubicin—stomach cancer	0.000266	0.000266	CcSEcCtD
Methylphenidate—Abdominal pain—Epirubicin—stomach cancer	0.000266	0.000266	CcSEcCtD
Methylphenidate—Body temperature increased—Epirubicin—stomach cancer	0.000266	0.000266	CcSEcCtD
Methylphenidate—Hypersensitivity—Methotrexate—stomach cancer	0.000265	0.000265	CcSEcCtD
Methylphenidate—Asthenia—Methotrexate—stomach cancer	0.000258	0.000258	CcSEcCtD
Methylphenidate—Feeling abnormal—Doxorubicin—stomach cancer	0.000256	0.000256	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000254	0.000254	CcSEcCtD
Methylphenidate—Pruritus—Methotrexate—stomach cancer	0.000254	0.000254	CcSEcCtD
Methylphenidate—Hypersensitivity—Epirubicin—stomach cancer	0.000248	0.000248	CcSEcCtD
Methylphenidate—Urticaria—Doxorubicin—stomach cancer	0.000247	0.000247	CcSEcCtD
Methylphenidate—Abdominal pain—Doxorubicin—stomach cancer	0.000246	0.000246	CcSEcCtD
Methylphenidate—Body temperature increased—Doxorubicin—stomach cancer	0.000246	0.000246	CcSEcCtD
Methylphenidate—Diarrhoea—Methotrexate—stomach cancer	0.000246	0.000246	CcSEcCtD
Methylphenidate—Asthenia—Epirubicin—stomach cancer	0.000241	0.000241	CcSEcCtD
Methylphenidate—Pruritus—Epirubicin—stomach cancer	0.000238	0.000238	CcSEcCtD
Methylphenidate—Dizziness—Methotrexate—stomach cancer	0.000238	0.000238	CcSEcCtD
Methylphenidate—Diarrhoea—Epirubicin—stomach cancer	0.00023	0.00023	CcSEcCtD
Methylphenidate—Hypersensitivity—Doxorubicin—stomach cancer	0.000229	0.000229	CcSEcCtD
Methylphenidate—Vomiting—Methotrexate—stomach cancer	0.000228	0.000228	CcSEcCtD
Methylphenidate—Rash—Methotrexate—stomach cancer	0.000226	0.000226	CcSEcCtD
Methylphenidate—Dermatitis—Methotrexate—stomach cancer	0.000226	0.000226	CcSEcCtD
Methylphenidate—Headache—Methotrexate—stomach cancer	0.000225	0.000225	CcSEcCtD
Methylphenidate—Asthenia—Doxorubicin—stomach cancer	0.000223	0.000223	CcSEcCtD
Methylphenidate—Dizziness—Epirubicin—stomach cancer	0.000222	0.000222	CcSEcCtD
Methylphenidate—Pruritus—Doxorubicin—stomach cancer	0.00022	0.00022	CcSEcCtD
Methylphenidate—Vomiting—Epirubicin—stomach cancer	0.000214	0.000214	CcSEcCtD
Methylphenidate—Nausea—Methotrexate—stomach cancer	0.000213	0.000213	CcSEcCtD
Methylphenidate—Diarrhoea—Doxorubicin—stomach cancer	0.000213	0.000213	CcSEcCtD
Methylphenidate—Rash—Epirubicin—stomach cancer	0.000212	0.000212	CcSEcCtD
Methylphenidate—Dermatitis—Epirubicin—stomach cancer	0.000212	0.000212	CcSEcCtD
Methylphenidate—Headache—Epirubicin—stomach cancer	0.000211	0.000211	CcSEcCtD
Methylphenidate—Dizziness—Doxorubicin—stomach cancer	0.000206	0.000206	CcSEcCtD
Methylphenidate—Nausea—Epirubicin—stomach cancer	0.0002	0.0002	CcSEcCtD
Methylphenidate—Vomiting—Doxorubicin—stomach cancer	0.000198	0.000198	CcSEcCtD
Methylphenidate—Rash—Doxorubicin—stomach cancer	0.000196	0.000196	CcSEcCtD
Methylphenidate—Dermatitis—Doxorubicin—stomach cancer	0.000196	0.000196	CcSEcCtD
Methylphenidate—Headache—Doxorubicin—stomach cancer	0.000195	0.000195	CcSEcCtD
Methylphenidate—Nausea—Doxorubicin—stomach cancer	0.000185	0.000185	CcSEcCtD
